Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Blood|August 18, 2010
Low-strength T-cell activation promotes Th17 responsesHarriet A Purvis, Jeroen N Stoop, Jelena Mann, et al.
Frontiers in Immunology|July 24, 2019
IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector FunctionLaura A Ridgley, Amy E Anderson, Nicola J Maney, et al.
BMJ Open|April 16, 2024
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutionsLeher Gumber, Opeyemi Agbeleye, Alex Inskip, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid ArthritisDarren Plant, Amy Webster, Nisha Nair, et al.
Annals of the Rheumatic Diseases|February 5, 2015
IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritisAmy E Anderson, Arthur G Pratt, Mamdouh A K Sedhom, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2020
Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease lociAlexander D Clark, Nisha Nair, Amy E Anderson, et al.
Drug Safety|June 11, 2016
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and PsoriasisMegan E B Clowse, Steven R Feldman, John D Isaacs, et al.
Medicine|June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trialStefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.
Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.
Pageof 21